Back
Milestone Pharmaceuticals Vs. Triumph Financial Industry Stock Comparison
Sell
44
MIST
Milestone Pharmaceuticals
Last Price:
$2.03
Seasonality Move:
-13.63%
Sell
24
TFIN
Triumph Financial
Last Price:
$59.85
Seasonality Move:
-6.74%
Sell
44
Milestone Pharmaceuticals (MIST)
is a Sell
Is Milestone Pharmaceuticals a Buy, Sell or Hold?
-
The current Milestone Pharmaceuticals [MIST] share price is $1.93. The Score for MIST is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
MIST is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
24
Triumph Financial (TFIN)
is a Sell
Is Triumph Financial a Buy, Sell or Hold?
-
The current Triumph Financial [TFIN] share price is $59.75. The Score for TFIN is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
-
TFIN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MIST Stock Price Chart
What is Milestone Pharmaceuticals's stock price today?
-
The Milestone Pharmaceuticals share price today is $1.93Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MIST is experiencing slight buying pressure.
TFIN Stock Price Chart
What is Triumph Financial's stock price today?
-
The Triumph Financial share price today is $59.75Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TFIN is experiencing slight selling pressure.
MIST Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 50.39 | Buy |
| Chaikin Money Flow: | 571613 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.78 - 2.2) | Sell |
| Bollinger Bands (100): | (1.63 - 2.11) | Buy |
TFIN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -5.18 | Sell |
| Relative Strength Index (14 RSI): | 22.25 | Sell |
| Chaikin Money Flow: | -10035 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (64.22 - 75.92) | Sell |
| Bollinger Bands (100): | (74.51 - 99.85) | Sell |
MIST Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.8 | Buy |
| 20-day SMA: | 1.97 | Sell |
| 50-day SMA: | 2.03 | Sell |
| 200-day SMA: | 1.67 | Buy |
| 8-day EMA: | 1.85 | Buy |
| 20-day EMA: | 1.91 | Buy |
| 50-day EMA: | 1.95 | Sell |
| 200-day EMA: | 1.86 | Buy |
TFIN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 63.14 | Sell |
| 20-day SMA: | 68.27 | Sell |
| 50-day SMA: | 78.12 | Sell |
| 200-day SMA: | 83.87 | Sell |
| 8-day EMA: | 62.79 | Sell |
| 20-day EMA: | 67.67 | Sell |
| 50-day EMA: | 75.94 | Sell |
| 200-day EMA: | 81.72 | Sell |
Milestone Pharmaceuticals Earnings Growth & MIST Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.20 per share, and an increase next year of $0.95 per share.
Triumph Financial Earnings Growth & TFIN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.15 per share, an increase next quarter of $0.10 per share, an increase this year of $0.38 per share, and an increase next year of $1.38 per share.
Milestone Pharmaceuticals Technical Analysis
| Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | Mar | |||||||||
| 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Triumph Financial Technical Analysis
| Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | Mar | |||||||||
| 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||